Centene Co. (NYSE:CNC) Shares Bought by Sendero Wealth Management LLC

Sendero Wealth Management LLC grew its stake in Centene Co. (NYSE:CNCFree Report) by 30.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 81,348 shares of the company’s stock after acquiring an additional 18,808 shares during the quarter. Sendero Wealth Management LLC’s holdings in Centene were worth $4,928,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Park Place Capital Corp raised its stake in Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after purchasing an additional 357 shares during the period. Private Trust Co. NA increased its holdings in shares of Centene by 75.3% during the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company’s stock worth $58,000 after buying an additional 332 shares during the last quarter. True Wealth Design LLC purchased a new stake in shares of Centene during the 3rd quarter valued at approximately $66,000. Venturi Wealth Management LLC grew its position in Centene by 77.3% in the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after acquiring an additional 507 shares during the period. Finally, EverSource Wealth Advisors LLC increased its stake in Centene by 104.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company’s stock worth $82,000 after acquiring an additional 630 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analyst Upgrades and Downgrades

CNC has been the topic of several recent analyst reports. Oppenheimer decreased their price target on Centene from $95.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, December 13th. UBS Group raised shares of Centene from a “neutral” rating to a “buy” rating and increased their target price for the stock from $79.00 to $80.00 in a research note on Friday, December 13th. Truist Financial reduced their price target on shares of Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a research note on Friday, December 13th. Wells Fargo & Company lowered their price objective on shares of Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Finally, Robert W. Baird decreased their price target on Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $80.92.

Get Our Latest Report on Centene

Insider Transactions at Centene

In other Centene news, Director Thomas Greco acquired 17,000 shares of the stock in a transaction dated Wednesday, December 18th. The stock was acquired at an average cost of $59.75 per share, with a total value of $1,015,750.00. Following the transaction, the director now owns 19,309 shares in the company, valued at $1,153,712.75. The trade was a 736.25 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Sarah London bought 4,117 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the transaction, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 45,010 shares of company stock valued at $2,660,276. 0.33% of the stock is currently owned by corporate insiders.

Centene Trading Down 0.3 %

CNC opened at $63.23 on Thursday. The business has a fifty day moving average price of $60.06 and a 200 day moving average price of $67.41. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Co. has a 12 month low of $55.03 and a 12 month high of $81.42. The stock has a market capitalization of $31.92 billion, a price-to-earnings ratio of 10.98, a PEG ratio of 0.82 and a beta of 0.46.

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.